News|Articles|May 1, 2005

Pharmaceutical Technology-05-01-2005
Volume 2005 Supplement
Issue 2

Minimizing Risk Through Technology

New technologies and improvements to existing ones can reduce contamination risk in aseptic processing.

External Link - article-160409.pdf

Articles in this issue

about 21 years ago

Article

A New Concept in Aseptic Filling: Closed-Vial Technology

about 21 years ago

Article

Aseptic Processing: A Vision of the Future

about 21 years ago

Article

Isolator Technology With the Patient in Mind

about 21 years ago

Article

Aseptic Production, Gowning Systems, and Airborne Contaminants

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

The FDA finalized a rule standardizing the NDC to a uniform, 12-digit format

Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers

ByMatt Sample

July 2nd 2026

BioPhorum formed a group aimed at accelerating innovation across small molecule manufacturing

BioPhorum Unites 20 Organizations to Modernize Small Molecule Production

ByZachary Zubulake

July 1st 2026

Blood drop, floating stem cells. Hematopoietic stem cell collection, regenerative medicine, blood-derived stem cells, donor therapy, transplantation concept | Image Credit: ©Елена Бутусова -stock.adobe.com

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

BySusan Haigney

July 1st 2026

Roche Gets Priority Review for Enspryng; Announces Sequencing Platform

BySusan Haigney

June 30th 2026

Antibody drug conjugate in blue with four drug compounds linked to IgG immunoglobulin; ADC in blue against blue background 3d render | Image Credit: ©huenstructurebio.com -stock.adobe.com

Lonza Increases HPAPI Production at Visp Facility

BySusan Haigney

June 30th 2026

Minimizing Risk Through Technology

Articles in this issue

Related Content

Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers

BioPhorum Unites 20 Organizations to Modernize Small Molecule Production

FDA Grants First-in-Class Approval for Treg Cell Therapy in Blood Cancer Transplant Patients

Roche Gets Priority Review for Enspryng; Announces Sequencing Platform

Lonza Increases HPAPI Production at Visp Facility

Trending on Pharmaceutical Technology

FDA Chooses 7 Companies for PreCheck Pilot

Preparing for Pharma’s “Y2K Moment”: What the Shift to a 12-Digit NDC Means for Manufacturers

Lonza Increases HPAPI Production at Visp Facility

Documentation Reliability Across Contractors: A Quality Systems Approach

Manufacturing Deficiencies Behind FDA's Oxylanthanum Carbonate Rejection